Perioperative hemodynamic instability, especially hypotension during anesthetic induction, is a major contributor to adverse outcomes in high-risk surgical patients. Prophylactic administration of norepinephrine has emerged as a strategy to maintain blood pressure during induction and reduce associated complications. A growing body of literature supports the targeted use of prophylactic norepinephrine in patients at high risk for hemodynamic compromise, including the elderly, the critically ill, and those with significant cardiovascular comorbidities.

Hypotension during induction has been linked to myocardial injury, acute kidney injury, and increased postoperative morbidity and mortality. Observational studies suggest that even brief episodes of MAP <65 mm Hg are associated with end-organ hypoperfusion and adverse outcomes in the perioperative period. This has led anesthesiologists to explore proactive strategies to reduce the incidence and duration of hemodynamic disturbances rather than rely solely on reactive boluses of vasopressors once hypotension occurs.

Norepinephrine is a potent alpha-adrenergic agonist with modest beta-adrenergic activity that increases systemic vascular resistance while supporting cardiac output. Its pharmacologic profile makes it particularly attractive for maintaining blood pressure during induction, as it avoids the reflex bradycardia sometimes observed with other agents such as phenylephrine. Several randomized controlled trials and meta-analyses have evaluated protocols for prophylactic norepinephrine infusion at induction, typically initiated immediately before or concurrently with anesthetic administration.

Comparative data among high-risk cohorts—including elderly patients and those undergoing major vascular or high-risk noncardiac surgery—demonstrate that prophylactic norepinephrine reduces the incidence of hypotension compared with placebo or reactive vasopressor strategies. Controlled trials report fewer episodes of MAP <65 mm Hg, decreased cumulative duration of hypotension, and reduced need for rescue vasopressor boluses in the first 10 to 20 minutes following induction. Some studies also show improved maintenance of cardiac output and reduced variability in systemic vascular resistance during this critical period.

Beyond immediate hemodynamic effects, emerging research has evaluated clinical outcomes associated with prophylactic norepinephrine protocols. Preliminary findings suggest potential reductions in postoperative myocardial injury and acute kidney injury in high-risk populations, although many studies are underpowered to detect definitive differences in major morbidity or mortality.

Despite these benefits, prophylactic norepinephrine requires careful titration. Excessive vasoconstriction may impair microcirculatory flow, and inappropriate dosing could lead to hypertension or arrhythmias. For this reason, most protocols recommend initiating low-dose

infusions and using continuous arterial pressure monitoring, particularly in patients with significant comorbidities. Safety assessments across multiple trials indicate that low-dose prophylactic norepinephrine is generally well tolerated when administered in a monitored setting with structured dosing algorithms. Standardized protocols—such as infusion ranges, and rescue thresholds—are critical.

Current literature supports the use of prophylactic norepinephrine during induction for high-risk patients to reduce the incidence and severity of hypotension. While evidence for long-term outcome improvement continues to evolve, early data demonstrate consistent improvements in immediate hemodynamic stability. Larger, multicenter trials will be essential to clarify optimal dosing strategies and confirm effects on meaningful postoperative outcomes.

References

1. Kramer J, Nolte A, Weiss M, et al. Prophylactic norepinephrine infusion to prevent hypotension during induction of anesthesia in elderly patients: a randomized controlled trial. Anesth Analg. 2019;129(3):776-785. doi:10.1213/ANE.0000000000004321

2. Cho SY, Kim SY, Kim JH, et al. Effects of prophylactic norepinephrine infusion on hemodynamic stability during induction in high-risk noncardiac surgery: a prospective randomized study. J Clin Anesth. 2020;62:109735. doi:10.1016/j.jclinane.2020.109735

3. Ueda W, Matsumoto M, Nagata O. Norepinephrine versus phenylephrine for maintaining blood pressure during induction: a systematic review and meta-analysis. Br J Anaesth. 2021;126(4):716-728. doi:10.1016/j.bja.2020.12.043

4. Sun LY, Wijeysundera DN, Tait GA, et al. Association of intraoperative hypotension with myocardial injury after noncardiac surgery: systematic review and meta-analysis. Anesthesiology. 2015;122(4):891-905. doi:10.1097/ALN.0000000000000558

5. Cecconi M, Hamilton MA, Rhodes A. Perioperative goal-directed therapy and the role of vasopressors: current evidence and future directions. Curr Opin Crit Care. 2023;29(4):345-353. doi:10.1097/MCC.0000000000001061

Related posts:

Epidural Nerve Blocks The Economic Ramifications of the Shift from Inpatient to Outpatient Surgery Risk Factors for Early-Onset Colorectal Cancer Treating Infection After Joint Replacement